CTN Webinar: Relapse Prevention.

CTN Webinar: Relapse Prevention. – This 90-minute webinar, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, explores the issue of relapse among individuals with substance use disorders (SUD). Outcome studies, types and effects of lapse and relapse, and factors contributing to relapse are reviewed. A major emphasis of the webinar is on discussing specific clinical strategies to reduce relapse risk, with a focus on current empirical and clinical literature, including findings from quality improvement studies and clinical trials conducted in a drug treatment clinic. The target audience is CTN members and other researchers and clinicians interested in learning more about relapse prevention. Presented by Dennis Daley, PhD, LSW (Western Psychiatric Institute and Clinic, AT Node) and Dennis M. Donovan, PhD (Alcohol & Drug Abuse Institute, University of Washington, PN Node). For more resources related to this webinar, as well as other webinars in this series, visit: ctndisseminationlibrary.org

Zacks Analyst Jason Napodano's Seven Biotech Picks Will Keep Your Profits on …

Filed under: drug abuse treatment outcome study

TLSR: Back on June 16, the company treated its 16th patient with stem cell injections in both the cervical and the lumbar region. This was the first patient ever to receive stem cells in two locations. Although this study is about safety, are we …
Read more on InvestorIdeas.com (press release)

AstraZeneca v European Commission, Case c-457/10 P

Filed under: drug abuse treatment outcome study

On 6 December 2012, the European Court of Justice (the “ECJ”) upheld the judgment of the General Court (“GC”), which found that AstraZeneca (“AZ”) abused its dominant position on the market for proton pump inhibitors (“PPIs”) by misleading patent …
Read more on Lexology (registration)